# First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/first-or-second-line-therapy-with-gefitinib-produces-equal-survival-in-non-small/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jenn‐Yu Wu,Chong‐Jen Yu,Chih-Hsin Yang,Shang‐Gin Wu,Yueh‐Hsia Chiu,Chien‐Hung Gow,Yeun‐Chung Chang,Y. L. Hsu,Pin‐Fei Wei,Jin‐Yuan Shih,Pan‐Chyr Yang |
| Citations | 70 |
| DOI | 10.1164/rccm.200803-389oc |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2045486039 |
| PMID | 18583573 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Pin‐Fei Wei](https://scholariq.org/researchers/pin-fei-wei/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.